Feasibility of completion thyroidectomy via transoral endoscopic vestibular approach
Updates in Surgery · 2024
DOI: 10.1007/s13304-024-01922-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Updates in Surgery, 2024. Verfasst von Tsung-Jung Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Rd, Zuoying District, Kaohsiung, 813414…. Hauptthemen laut MEDLINE: Thyroidectomy, Feasibility Studies, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of General Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Rd, Zuoying District, Kaohsiung, 813414, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, No.155, Sec. 2, Linong Street, Taipei, 112304, Taiwan.
- Division of General Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Rd, Zuoying District, Kaohsiung, 813414, Taiwan. citagun@yahoo.com.
- School of Medicine, National Yang Ming Chiao Tung University, No.155, Sec. 2, Linong Street, Taipei, 112304, Taiwan. citagun@yahoo.com.
Zitieren
APA
Liang, T. J., Chen, I. S., Chen, Y. C., & Liu, S. I. (2024). Feasibility of completion thyroidectomy via transoral endoscopic vestibular approach. Updates in Surgery. https://doi.org/10.1007/s13304-024-01922-3
Vancouver
Liang TJ, Chen IS, Chen YC, Liu SI. Feasibility of completion thyroidectomy via transoral endoscopic vestibular approach. Updates in Surgery. 2024. doi:10.1007/s13304-024-01922-3
BibTeX
@article{Liang2024,
author = {Liang, Tsung-Jung and Chen, I-Shu and Chen, Yu-Chia and Liu, Shiuh-Inn},
title = {Feasibility of completion thyroidectomy via transoral endoscopic vestibular approach},
journal = {Updates in Surgery},
year = {2024},
doi = {10.1007/s13304-024-01922-3}
}
EUVIMED